Interestingly, non-neoplastic astrocytes did not show any sign of apoptosis after RAB38 knockdown (Figure 2a), demonstrating that RAB38 could be a selective therapeutic target for glioblastoma. This evidence concerns the gene RAB38 and glioblastoma.